An outside vaccine advisory panel for the Centers for Disease Control and Prevention (CDC) today voted to recommend the single-dose Johnson & Johnson COVID-19 vaccine after discussing study findings and policy and clinical considerations.Their interim recommendation, moving a third vaccine option just a step away from distribution, comes on the heels of the Food and Drug Administration (FDA) emergency use authorization (EUA) announcement last night, accepting its advisory group's recommendation.The CDC usually accepts the recommendations of its Advisory Committee on Immunization Practices (ACIP), and a formal CDC announcement will be the final step that clears vaccination to begin.Distribution will start this week, with 2 million doses